HDACs/mTOR Inhibitor 1
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-114414-100 mg |
| CAS # | 2271413-06-8 |
| Pricing | 100 mg, USD $3350.0 |
| Biological Activity | HDACs/mTOR Inhibitor 1 is a dual Histone Deacetylases (HDACs) and mammalian target of Rapamycin (mTOR) target inhibitor for treating hematologic malignancies, with IC50s of 0.19 nM, 1.8 nM, 1.2 nM and >500 nM for HDAC1, HDAC6, mTOR and PI3Kα, respectively. HDACs/mTOR Inhibitor 1 stimulates cell cycle arrest in G0/G1 phase and induce tumor cell apoptosis with low toxicity in vivo[1]. |
| Purity | 99.12% |
| MWt | 566.65 |
| Formula | C₂₈H₃₈N₈O₅ |